# Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX Regime

> **NCT03542136** · NA · COMPLETED · sponsor: **Lund University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** VibrosSense Meter®

## Key facts

- **NCT ID:** NCT03542136
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-04
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542136, "Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX Regime". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03542136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*